Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells

  • Authors:
    • Monika Krmenčíková
    • Libor Staněk
    • Martina Petráčková
    • Pavel Dundr
    • Vladimír Vonka
  • View Affiliations

  • Published online on: September 28, 2011     https://doi.org/10.3892/ijo.2011.1213
  • Pages: 487-493
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated whether a genetic modification of BCR-ABL-transformed mouse cells that resulted in endostatin (ES) production altered their oncogenic potential. Mouse B210 cells, which express p210bcr-abl fusion protein and induce leukemia-like disease and extremely rarely solid tumors after intravenous (i.v.) administration, were used. The cells were transfected with a plasmid carrying genes for mouse ES and resistance to blasticidine. Transduced cells were isolated in media supplemented with blasticidine. Production of ES was determined by Western blotting. For further tests, two clones were selected, and their pathogenicity after i.v. inoculation was tested. Compared with the parental B210 cells, the capability of both gene-modified cell clones to induce lethal leukemia was reduced. However, mice that did not succumb to leukemia subsequently developed solid tumors. They were composed of poorly differentiated cells with irregular nuclei and roughly granular chromatin and were well vascularized. FISH revealed the presence of the BCR-ABL fusion gene both in tumors and spleens. Immunohistological investigation of the tumors demonstrated the production of ES in vivo and the cell lines derived from the tumors produced detectable amounts of ES, this demonstrating that the formation of solid tumors was not associated with the loss or silencing of the ES gene.

Related Articles

Journal Cover

February 2012
Volume 40 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Krmenčíková, M., Staněk, L., Petráčková, M., Dundr, P., & Vonka, V. (2012). Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells. International Journal of Oncology, 40, 487-493. https://doi.org/10.3892/ijo.2011.1213
MLA
Krmenčíková, M., Staněk, L., Petráčková, M., Dundr, P., Vonka, V."Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells". International Journal of Oncology 40.2 (2012): 487-493.
Chicago
Krmenčíková, M., Staněk, L., Petráčková, M., Dundr, P., Vonka, V."Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells". International Journal of Oncology 40, no. 2 (2012): 487-493. https://doi.org/10.3892/ijo.2011.1213